Allergen activates eosinophils of atopic bronchial asthma patients via IgE-mediated mechanism. Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020
Changes in lung functions and inflammatory markers in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens Source: Eur Respir J 2005; 26: Suppl. 49, 734s Year: 2005
Humoral markers of inflammation in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens Source: Eur Respir J 2004; 24: Suppl. 48, 595s Year: 2004
Immunotherapy prevents the development of asthma in subjects with allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001
Sputum induction elicits different peripheral airways responses in healthy subjects, asthma and allergic rhinitis patients Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015
Influence of endogenous corticosteroids on bronchial protective properties of β2 -agonist in patients with bronchial asthma with cold bronchial hyperresponsiveness Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010
Omalizumab protects against allergen-induced bronchoconstriction in patients with allergic (IgE-mediated) asthma and high baseline IgE levels Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Interdepedence between cytokines and antioxidants in lymphocytes of patients with bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 590s Year: 2005
Clinical relevance of anti-inflammatory treatment of rhinitis for the course and prognosis of allergic bronchial asthma Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007
Interactions between antiviral and atopic inflammatory pathways sustain asthma exacerbations in children Source: Annual Congress 2009 - Infections, immunity and inflammation Year: 2009
Cytokine regulation of the chronicle inflammation of bronchial asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 590s Year: 2005
The effect of vitamin D therapy on airway reactivity and airway inflammation in asthmatic children Source: Annual Congress 2013 –Preschool wheeze Year: 2013
IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status? Source: International Congress 2017 – Monitoring asthma control Year: 2017
Markers of inflammation and airway responses to allergen in asthmatic patients Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
Sublingual monomeric allergoid immunotherapy improves airway inflammation, airway hyperresponsiveness and clinical symptoms in allergic rhinitis and asthma Source: Eur Respir J 2006; 28: Suppl. 50, 439s Year: 2006
Omalizumab reduces bronchial mucosal IgE and improves lung function in non-atopic asthma Source: Eur Respir J 2016; 48: 1593-1601 Year: 2016
Inhaled corticosteroids and β2 -agonists reduces imbalance in the cellular redox status in patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 508s Year: 2004
Specific allergen immunotherapy of asthma combined with allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 441s Year: 2006
Comparison of late allergic inflammatory responses in asthma and rhinitis after nasal and bronchial allergen challenge Source: Eur Respir J 2001; 18: Suppl. 33, 269s Year: 2001
Inflammatory markers in induced sputum of patients with allergic rhinitis in relation to exposure to pollen allergens Source: Eur Respir J 2006; 28: Suppl. 50, 444s Year: 2006